AAR Corp. (NYSE:AIR): Because of both the company’s restructuring and weak pull in the defense industry. EarlyBirdCapital lowered estimates and its price target for AAR Corp. The firm maintains it’s Buy rating on the stock.
NewLink Genetics Corp (NASDAQ:NLNK): Following NewLink’s confirmation that a Phase III HyperAcute Pancreas trial of the company’s algenpantucel-L vaccine passed the enrollment mark of 50%, Cantor believes the trial will be completely enrolled before 2014. Because the firm sees a compelling outlook for the vaccine, it reiterates its Buy rating on the shares.
SM Energy Company (NYSE:SM): In order to reflect price reductions in both NGLs and oil within the past two months, Barrington reduced its target for SM Energy, but the firm does not believe that the stocks valuation reflects a rise in the proportion of oil and liquids in the company’s reserves. Barrington reiterates an Outperform rating on the shares.
Zumiez, Inc. (NASDAQ:ZUMZ): As a result of the Blue Tomato acquisition and increased guidance, Caris has raised estimates for Zumiez. The Firm gives Zumiez a Buy rating.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.